Advertisement

Synthesis and Cardiotropic Activity of Cyclic Methoxyphenyltriazaalkanes

  • G. V. MokrovEmail author
  • A. M. Likhosherstov
  • V. V. Barchukov
  • V. N. Stolyaruk
  • I. B. Tsorin
  • M. B. Vititnova
  • A. G. Rebeko
  • S. A. Kryzhanovskii
  • T. A. Gudasheva
SEARCH FOR NEW DRUGS

A new group of compounds – 1-(methoxybenzyl)-4-[2-((methoxybenzyl)amino)ethyl]piperazin-2,3-diones was synthesized. As compared with previously studied linear methoxyphenyltriazaalkanes, the structure of the triazaalkane linker was found to influence the cardiotropic actions of the corresponding compounds. The most effective among the new group was 1-(2,4-dimethoxybenzyl)-4{2-[2,4-dimethoxybenzyl)amino]ethyl}piperazin-2,3-dione, which had significant antiarrhythmic activity at a dose of 2 mg/kg in a calcium chloride arrhythmia model, along with activity at the level of a tendency in models of aconitin arrythmia and reperfusion ventricular fibrillation.

Keywords

pFOX inhibitors antiischemic and antiarrhythmic activity linear and cyclic methoxyphenyltriazaalkanes 

References

  1. 1.
    G. V. Mokrov, A. M. Likhosherstov, V. V. Barchukov, et al., Khim.-Farm. Zh., 53(6), 37 – 44 (2019).Google Scholar
  2. 2.
    P. F. Kantor, A. Lucien, R. Kozak, and G. D. Lopaschuk, Circ. Res., 86(5), 580 – 588 (2000).CrossRefGoogle Scholar
  3. 3.
    M. Aldakkak, A. K. Camara, J. S. Heisner, et al., Pharmacol. Res., 64(4), 381 – 392 (2011).CrossRefGoogle Scholar
  4. 4.
    Guidelines for Preclinical Studies of Drugs [in Russian], A. N. Mironov (ed.), Grif i K, Moscow (2013), Part 1, pp. 385 – 416.Google Scholar
  5. 5.
    I. A. Ilyushkina, A. N. Berchatova, I. A. Dyachenko, et al., Biomeditsina, No. 2, 6 – 13 (2012).Google Scholar
  6. 6.
    S. Yamamoto, K. Matsui, M. Sasabe, and N. Ohashi, J. Cardiovasc. Pharmacol., 39(2), 234 – 241 (2002).Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • G. V. Mokrov
    • 1
    Email author
  • A. M. Likhosherstov
    • 1
  • V. V. Barchukov
    • 1
  • V. N. Stolyaruk
    • 1
  • I. B. Tsorin
    • 1
  • M. B. Vititnova
    • 1
  • A. G. Rebeko
    • 1
  • S. A. Kryzhanovskii
    • 1
  • T. A. Gudasheva
    • 1
  1. 1.V. V. Zakusov Science Research Institute of PharmacologyMoscowRussia

Personalised recommendations